Esteem Bio IPO Latest News Today

Track all the latest updates and news of Esteem Bio IPO.

1. Boundless Bio boldly goes public with $100M IPO

   March 28, 2024 10:40:00 AM

   Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...

   Published by : FierceBiotech

2. Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasnt fully recovered just yet

   April 23, 2024 7:30:15 PM

   Biotech IPOs surged at the start of 2024, but the rest of the year will depend on Fed rate cuts. Meanwhile, doctors using VR and AI to hone their skills.

   Published by : CNBC on MSN

3. Boundless Bio�s �BOLD� IPO Reels In $100M for a New Kind of Cancer Drug

   March 28, 2024 4:45:00 PM

   Boundless Bio�s research into what drives this phenomenon has yielded new understanding of cancer biology. The company now has $100 million in IPO cash to support two programs in early clinical ...

   Published by : MedCity News

4. Boundless Bio, Inc IPOs Tomorrow, Heres What You Need To Know

   March 27, 2024 2:30:00 PM

   BOUNDLESS BIO, INC BOLD IPO will take place March, 28 on the NASDAQ exchange under the ticker BOLD. The company is offering shares at an expected price between $15.00 and $17.00 per share with an ...

   Published by : Benzinga.com

5. Contineum lowers expectations for $110M IPO as J&J-allied biotech goes public

   April 5, 2024 10:30:00 AM

   Contineum Therapeutics has lowered its IPO expectations as the Johnson & Johnson-partnered biotech prepares to make the jump to the public markets this morning Friday, April 5. The San Diego-based ...

   Published by : FierceBiotech

6. Ibotta IPO Reportedly Raises $577 Million�Above Marketed Range

   April 18, 2024 3:44:00 AM

   Ibotta and shareholders sold 6.56 million shares for $88 each, Bloomberg reported, exceeding the company�s estimated IPO price, which was put between $76 and $84. Selling the shares for $88 each ...

   Published by : Forbes

7. Boundless Bio breaks IPO lull with $100M fundraise

   March 28, 2024 3:31:00 AM

   Boundless Bio, a cancer drug developer backed by Bayer ... ending a short break in biotech IPO activity. Still, new stock issuances have now totaled $1.3 billion in 2024, the most for the sector ...

   Published by : Yahoo Finance

8. Boundless Bio Readies $94 Million U.S. IPO Effort

   March 25, 2024 5:14:00 PM

   Boundless Bio (BOLD) has filed proposed terms to raise $94 million from the sale of its common stock in an IPO, according to an amended SEC registration statement. The firm is a clinical stage ...

   Published by : Seeking Alpha

9. Bayer-backed Boundless Bio sees stock fall 8% after $100M IPO

   March 28, 2024 10:21:00 PM

   Bayer Healthcare (OTCPK:BAYZF) (OTCPK:BAYRY) held a 9% stake in the company ahead of the IPO. Based in San Diego, Boundless Bio is developing ecDNA-directed therapeutics called ecDTx along with a ...

   Published by : Seeking Alpha

10. Investors Rush to Buy Ibotta Stock in its IPO

    April 19, 2024 2:34:00 AM

    Enthusiasm for IPOs is growing, and the latest beneficiary is Ibotta, a Denver-based digital-rewards company. Ibotta, whose name is a nod to the phrase �I bought a,� picked its stock-market ...

    Published by : Wall Street Journal

11. What You Need To Know About UL Solutions IPO

    April 2, 2024 3:30:00 AM

    UL Solutions filed for an initial public offering (IPO) Tuesday, aiming to raise up to $812 million. UL Solutions, which provides safety-focused testing, inspection, and certification services ...

    Published by : Investopedia

Esteem Bio IPO Alerts